SVB Leerink Maintains Outperform on Bruker, Raises Price Target to $87
SVB Leerink analyst Puneet Souda maintains Bruker (NASDAQ:BRKR) with a Outperform and raises the price target from $85 to $87.
Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Goldman Sachs Maintains Sell on Bruker, Lowers Price Target to $60
Goldman Sachs maintains Bruker (NASDAQ:BRKR) with a Sell and lowers the price target from $73 to $60.
Bruker Announces Key Innovations For Multiplexed Spatial Proteomics And Unbiased Multiomic Imaging For Cancer Research At AACR 2022 Annual Meeting
At the AACR Annual Meeting 2022, Bruker Corporation (NASDAQ:BRKR) launched and exhibited unique and novel capabilities for spatial multiomics, single-cell proteomics, and cell-line, tissue and plasma proteomics
SVB Leerink Maintains Outperform on Bruker, Raises Price Target to $85
SVB Leerink analyst Puneet Souda maintains Bruker (NASDAQ:BRKR) with a Outperform and raises the price target from $84 to $85.
Recap: Bruker Q4 Earnings
Bruker (NASDAQ:BRKR) reported its Q4 earnings results on Friday, February 11, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings Scheduled For February 11, 2022
Companies Reporting Before The Bell
• Mr. Cooper Group (NASDAQ:COOP) is expected to report quarterly earnings at $1.22 per share on revenue of $551.60 million.
A Preview Of Bruker’s Earnings
Bruker (NASDAQ:BRKR) is set to give its latest quarterly earnings report on Friday, 2022-02-11. Here's what investors need to know before the announcement.
Analysts estimate that Bruker will likely report an Earnings Per Share (EPS) of $0.58.
Bruker Reports Purchase Of PepSep, No Terms Disclosed
Acquires PepSep NanoLC Columns and Components Company for ease-of-use and robustness
Enters into OEM agreement with IonOpticks for high-performance nanoLC Aurora columns
Complementary PepSep and IonOpticks